Trending
- Lilly’s triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C
- County spends $1.5M on GLP-1 weight loss drugs, may offer employees gym passes instead
- CI Investments Inc. Buys New Shares in Atour Lifestyle Holdings Limited Sponsored ADR $ATAT
- Maine reports another case of rare tick
- Ozempic face? Botox maker reports boost from ‘sagging face’ trend
- iFIT and Samsung Health Deepen Partnership with Launch of iFIT Personal Trainer on Galaxy Devices
- Bama Health Foods reopens with Nourish Grocer now accepting EBT in West Birmingham
- Delaware Declares Measles Outbreak
Thursday, July 23